Schinifoline is primarily used in pharmacological research due to its biological activity. It exhibits antimicrobial and anti-inflammatory properties, making it a candidate for development in therapeutic agents. Studies suggest potential application in treating bacterial infections and inflammatory conditions. Its ability to interact with cellular pathways also supports exploration in neuroprotective and anticancer research. However, practical use remains limited to laboratory and experimental settings, with no widespread clinical application established to date.